comparemela.com

Latest Breaking News On - G protein coupled receptor - Page 12 : comparemela.com

ORION BIOTECHNOLOGY ADDS INDUSTRY LEADER TO BOARD OF DIRECTORS

ORION BIOTECHNOLOGY ADDS INDUSTRY LEADER TO BOARD OF DIRECTORS
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

Proteomics Market worth $ 73 17 Billion, Globally, by 2028 at 16 50% CAGR: Verified Market Research™

Share this article Share this article Jersey City, N.J., June 9, 2021 /PRNewswire/ Verified Market Research recently published a report, Proteomics Market By Reagent (Protein Microarray Reagents, X – Ray Crystallography Reagents, Electrophoresis Reagents & Others), By Instrumentation Technology (X – Ray Crystallography, Surface Plasmon Resonance, Protein Fractionation & Others), By Software and Service (Core Proteomics Services and Bioinformatics Software and Services), By Application (Clinical Diagnostics, Drug Discovery and Other Applications), and By Geography. According to Verified Market Research, the Global Proteomics Market was valued at USD 21.64 Billion in 2020 and is projected to reach USD 73.17 Billion by 2028, growing at a CAGR of 16.50% from 2021 to 2028.

Proteomics Market worth $ 73 17 Billion, Globally, by 2028 at 16 50% CAGR: Verified Market Research

Philippe Dro Joins Adjuvant Capital as Partner

Philippe Dro Joins Adjuvant Capital as Partner Biopharma and Medical Device Entrepreneur Joins to Strengthen Global Health Investment Team and Establish a Formal Presence in Europe News provided by Share this article NEW YORK, April 29, 2021 /PRNewswire/   Adjuvant Capital, a life science investment firm focused on global health, today announced that Phillipe Dro, Pharm. D., MBA, will join as a partner and be based in Zurich, Switzerland. As a seasoned biopharma and medical device entrepreneur and executive with more than 25 years of experience, Dr. Dro brings significant operational, scientific, technical and product development expertise to the Adjuvant Capital team. He is currently chairman of the Board of Amsterdam-based Scenic Biotech, as well as Swiss companies, Luciole Medical and LimmaTech Biologics.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.